EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Anti‐Alzheimer Evaluation and In Silico Study of 4‐Methoxyphenyl)Sulfonyl Indole Hybrid Thiosemicarbazones

Uzma Ghaffar, Zahra Batool, Mussarat Tasleem iD, Nastaran Sadeghian, Parham Taslimi iD, Suraj N Mali iD, Kholood A Dahlous, Rahul D Jawarkar, Shailesh S Gurav, Xianliang Zhao, Iqra Munir, Zahid Shafiq iD

Archiv der Pharmazie · 2025-07 · 358 (7)

DOI: 10.1002/ardp.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 10.07.2025. Verfasst von Uzma Ghaffar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Monoamine Oxidase Inhibitors, Alzheimer Disease, Thiosemicarbazones. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: This study was funded by the Researchers Supporting Project Number (RSP2025R388), King Saud University, Riyadh, Saudi Arabia..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a multifaceted neurological disorder linked to behavioral, psychological, and language abnormalities as well as memory loss. A series of 1‐[(4‐methoxyphenyl)sulfonyl]−1 H ‐indole‐3‐carbaldehyde‐based thiosemicarbazones 5(a–v) had been synthesized and screened for their potential against AD. The compounds were tested for their inhibitory effects against cholinesterases (AChE and BChE) and monoamine oxidase A (MAO‐A). Compounds 5l , 5v , and 5r showed remarkable activity on AChE, BChE, and MAO‐A enzymes, having IC 50 values ranging between 1.57 and 4.56 nM ( K i = 1.43 ± 0.44 to 3.43 ± 0.21 nM), between 25.68 and 35.06 nM ( K i = 22.53 ± 7.70 to 34.82 ± 2.32 nM), and between 22.98 and 27.23 nM, respectively. Compound 5l with trifluoromethyl substitution at the 3 and 5 positions was the most effective derivative of AChE and BChE, having K i values of 1.43 ± 0.44 nM and 22.53 ± 7.70 nM, respectively. Compound 5v with chloro substitution at the 2 and 6 positions of the phenyl ring was the most potent inhibitor of MAO‐A, with IC 50 values of 22.98 nM. Structure–activity analysis exhibited that the electron‐withdrawing substituents and di‐substitution on the phenyl ring play a significant role in the inhibition potential of synthesized compounds. The most effective inhibitors’ binding interactions with the active sites of AChE, BChE, and MAO‐A were described via molecular docking studies. In silico ADME, pharmacokinetics, and drug‐likeness studies were conducted and compared with the standard drugs galantamine and clorgyline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsMonoamine Oxidase InhibitorsAlzheimer DiseaseThiosemicarbazonesIndolesStructure-Activity RelationshipMonoamine OxidaseHumansMolecular Docking SimulationAcetylcholinesteraseMolecular StructureDose-Response Relationship, DrugButyrylcholinesteraseComputer Simulation

Stichwörter der Autor:innen

4‐methoxyphenyl)sulfonylAlzheimer's diseasein silico ADMEpharmacokineticsthiosemicarbazones

Substanzen

Cholinesterase InhibitorsMonoamine Oxidase InhibitorsThiosemicarbazonesIndolesMonoamine OxidaseAcetylcholinesteraseButyrylcholinesterase

Autor:innen und Institutionen

  • Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
  • Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey.
  • School of Pharmacy, D.Y. Patil University (Deemed to be University), Navi Mumbai, India.
  • Department of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
  • Department of Medicinal Chemistry, Dr. Rajendra Gode Institute of Pharmacy, Amravati, India.
  • Department of Chemistry, VIVA College, Virar, Maharashtra, India.

ORCID-Profile: Mussarat Tasleem, Parham Taslimi, Suraj N Mali, Zahid Shafiq

Förderung

  • This study was funded by the Researchers Supporting Project Number (RSP2025R388), King Saud University, Riyadh, Saudi Arabia.

Zitieren

APA

Ghaffar, U., Batool, Z., Tasleem, M., Sadeghian, N., Taslimi, P., Mali, S. N., Dahlous, K. A., Jawarkar, R. D., Gurav, S. S., Zhao, X., Munir, I., & Shafiq, Z. (2025). Synthesis, Anti‐Alzheimer Evaluation and In Silico Study of 4‐Methoxyphenyl)Sulfonyl Indole Hybrid Thiosemicarbazones. Archiv der Pharmazie, 358(7). https://doi.org/10.1002/ardp.70034

Vancouver

Ghaffar U, Batool Z, Tasleem M, Sadeghian N, Taslimi P, Mali SN, et al. Synthesis, Anti‐Alzheimer Evaluation and In Silico Study of 4‐Methoxyphenyl)Sulfonyl Indole Hybrid Thiosemicarbazones. Archiv der Pharmazie. 2025;358(7). doi:10.1002/ardp.70034

BibTeX
@article{Ghaffar2025,
  author = {Ghaffar, Uzma and Batool, Zahra and Tasleem, Mussarat and Sadeghian, Nastaran and Taslimi, Parham and Mali, Suraj N and Dahlous, Kholood A and Jawarkar, Rahul D and Gurav, Shailesh S and Zhao, Xianliang and Munir, Iqra and Shafiq, Zahid},
  title = {Synthesis, Anti‐Alzheimer Evaluation and In Silico Study of 4‐Methoxyphenyl)Sulfonyl Indole Hybrid Thiosemicarbazones},
  journal = {Archiv der Pharmazie},
  year = {2025},
  volume = {358},
  number = {7},
  doi = {10.1002/ardp.70034}
}
Kostenlos starten →